NO984143L - Ny prosess for å fremstille overflatemodifiserende stoffer - Google Patents

Ny prosess for å fremstille overflatemodifiserende stoffer

Info

Publication number
NO984143L
NO984143L NO984143A NO984143A NO984143L NO 984143 L NO984143 L NO 984143L NO 984143 A NO984143 A NO 984143A NO 984143 A NO984143 A NO 984143A NO 984143 L NO984143 L NO 984143L
Authority
NO
Norway
Prior art keywords
new process
surface modifying
producing surface
modifying substances
heparin
Prior art date
Application number
NO984143A
Other languages
English (en)
Other versions
NO984143D0 (no
Inventor
Elisabeth Scholander
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Priority to NO984143A priority Critical patent/NO984143L/no
Publication of NO984143D0 publication Critical patent/NO984143D0/no
Priority to AU57652/99A priority patent/AU757913B2/en
Priority to JP2000568523A priority patent/JP4152075B2/ja
Priority to DE69909104T priority patent/DE69909104T2/de
Priority to ES99944936T priority patent/ES2203177T3/es
Priority to BRPI9913516-7A priority patent/BR9913516B1/pt
Priority to PT99944936T priority patent/PT1112097E/pt
Priority to KR1020017002986A priority patent/KR100669132B1/ko
Priority to US09/763,873 priority patent/US6461665B1/en
Priority to EP99944936A priority patent/EP1112097B1/en
Priority to AT99944936T priority patent/ATE243538T1/de
Priority to CA002342991A priority patent/CA2342991C/en
Priority to PCT/NO1999/000277 priority patent/WO2000013718A1/en
Priority to DK99944936T priority patent/DK1112097T3/da
Publication of NO984143L publication Critical patent/NO984143L/no
Priority to NO20011182A priority patent/NO321029B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0029—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using an intermediate layer of polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Materials Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfinnelsen vedrører en ny prosess for å fremstille overflatemodifikasjoner med en forbedret antitrombogen virkning og de overflatemodifiserte substratene som dermed blir fremstilt.
NO984143A 1998-09-09 1998-09-09 Ny prosess for å fremstille overflatemodifiserende stoffer NO984143L (no)

Priority Applications (15)

Application Number Priority Date Filing Date Title
NO984143A NO984143L (no) 1998-09-09 1998-09-09 Ny prosess for å fremstille overflatemodifiserende stoffer
DK99944936T DK1112097T3 (da) 1998-09-09 1999-09-08 Ny fremgangsmåde til fremstilling af substanser til overflademodificering
PT99944936T PT1112097E (pt) 1998-09-09 1999-09-08 Processo novo para preparar substancias de modificacao de superficies
US09/763,873 US6461665B1 (en) 1998-09-09 1999-09-08 Process for preparing surface modification substances
DE69909104T DE69909104T2 (de) 1998-09-09 1999-09-08 Neues verfahren zur herstellung von mitteln zur oberflächenbehandlung
ES99944936T ES2203177T3 (es) 1998-09-09 1999-09-08 Nuevo procedimiento para preparar sustancias de modificacion de superficies.
BRPI9913516-7A BR9913516B1 (pt) 1998-09-09 1999-09-08 processo para a produção de uma modificação em superfìcie que tem uma atividade não trombogênica melhorada.
AU57652/99A AU757913B2 (en) 1998-09-09 1999-09-08 New process for preparing surface modification substances
KR1020017002986A KR100669132B1 (ko) 1998-09-09 1999-09-08 표면 개질을 생성하는 신규 방법
JP2000568523A JP4152075B2 (ja) 1998-09-09 1999-09-08 表面改質物質を調整する新方法
EP99944936A EP1112097B1 (en) 1998-09-09 1999-09-08 New process for preparing surface modification substances
AT99944936T ATE243538T1 (de) 1998-09-09 1999-09-08 Neues verfahren zur herstellung von mitteln zur oberflächenbehandlung
CA002342991A CA2342991C (en) 1998-09-09 1999-09-08 Antithrombogenic surfaces comprising immobilized heparin and methods for producing same
PCT/NO1999/000277 WO2000013718A1 (en) 1998-09-09 1999-09-08 New process for preparing surface modification substances
NO20011182A NO321029B1 (no) 1998-09-09 2001-03-08 Ny fremgangsmate for a fremskaffe overflatemodifikasjon samt overflatemodifisert substrat.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO984143A NO984143L (no) 1998-09-09 1998-09-09 Ny prosess for å fremstille overflatemodifiserende stoffer

Publications (2)

Publication Number Publication Date
NO984143D0 NO984143D0 (no) 1998-09-09
NO984143L true NO984143L (no) 2000-03-10

Family

ID=19902393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984143A NO984143L (no) 1998-09-09 1998-09-09 Ny prosess for å fremstille overflatemodifiserende stoffer

Country Status (14)

Country Link
US (1) US6461665B1 (no)
EP (1) EP1112097B1 (no)
JP (1) JP4152075B2 (no)
KR (1) KR100669132B1 (no)
AT (1) ATE243538T1 (no)
AU (1) AU757913B2 (no)
BR (1) BR9913516B1 (no)
CA (1) CA2342991C (no)
DE (1) DE69909104T2 (no)
DK (1) DK1112097T3 (no)
ES (1) ES2203177T3 (no)
NO (1) NO984143L (no)
PT (1) PT1112097E (no)
WO (1) WO2000013718A1 (no)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254564B1 (en) 1998-09-10 2001-07-03 Percardia, Inc. Left ventricular conduit with blood vessel graft
SE515295C2 (sv) 1999-11-23 2001-07-09 Medicarb Ab Förfarande för framställning av konjugat av en biologiskt aktiv polysackarid och ett fast substrat, samt sådana konjugat
WO2003094788A2 (en) * 2002-05-10 2003-11-20 Salviac Limited An embolic protection system
US6926965B2 (en) * 2002-09-11 2005-08-09 Novartis Ag LbL-coated medical device and method for making the same
US8071569B2 (en) * 2002-09-20 2011-12-06 Mousa Shaker A Oxidized heparin fractions and their use in inhibiting angiogenesis
US20050281857A1 (en) * 2004-05-25 2005-12-22 Heyer Toni M Methods and reagents for preparing biomolecule-containing coatings
US20060159650A1 (en) * 2005-01-14 2006-07-20 Bacterin, Inc. Composition and method for covalently coupling an antithrombotic substance and a hydrophilic polymer
DE102005003632A1 (de) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Katheter für die transvaskuläre Implantation von Herzklappenprothesen
CA2630823C (en) 2005-12-13 2015-02-10 Exthera Ab Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood
US9114194B2 (en) * 2006-05-12 2015-08-25 W. L. Gore & Associates, Inc. Immobilized biologically active entities having high biological activity following mechanical manipulation
US8986713B2 (en) * 2006-05-12 2015-03-24 W. L. Gore & Associates, Inc. Medical device capable of being compacted and expanded having anti-thrombin III binding activity
US8021677B2 (en) 2006-05-12 2011-09-20 Gore Enterprise Holdings, Inc. Immobilized biologically active entities having a high degree of biological activity
US8496953B2 (en) * 2006-05-12 2013-07-30 W. L. Gore & Associates, Inc. Immobilized biologically active entities having a high degree of biological activity following sterilization
US8733557B2 (en) 2006-09-15 2014-05-27 Toray Industries, Inc. Substrate and method for production thereof
US20080200421A1 (en) 2007-02-21 2008-08-21 Zhao Jonathon Z Coating for a medical device having an anti-thrombotic conjugate
US20090281059A1 (en) 2007-02-21 2009-11-12 Robert Falotico Coating for a medical device having an anti-thrombotic conjugate
US9693841B2 (en) 2007-04-02 2017-07-04 Ension, Inc. Surface treated staples, sutures and dental floss and methods of manufacturing the same
WO2008122034A1 (en) 2007-04-02 2008-10-09 Ension, Inc. Process for preparing a substrate coated with a biomolecule
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US8383156B2 (en) 2007-04-30 2013-02-26 Cordis Corporation Coating for a medical device having an anti-thrombotic conjugate
WO2008155683A1 (en) 2007-06-18 2008-12-24 Firmenich Sa Malodor counteracting compositions and method for their use
AU2008265838A1 (en) * 2007-06-18 2008-12-24 Exthera Medical Llc Device and method for restoration of the condition of blood
US20090018646A1 (en) 2007-07-10 2009-01-15 Zhao Jonathon Z Coating Employing an Anti-Thrombotic Conjugate
US20090192079A1 (en) * 2007-10-09 2009-07-30 Genzyme Corporation Prolonged delivery of heparin-binding growth factors from heparin-derivatized collagen
WO2011104269A1 (en) 2008-02-26 2011-09-01 Jenavalve Technology Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
GB0816783D0 (en) * 2008-09-15 2008-10-22 Carmeda Ab Immobilised biological entities
US7819914B2 (en) 2008-12-16 2010-10-26 Cordis Corporation Adhesion promoting primer for coated surfaces
US20100161039A1 (en) 2008-12-23 2010-06-24 Vipul Dave Adhesion promoting temporary mask for coated surfaces
AU2010200316A1 (en) * 2009-01-30 2010-08-19 Cordis Corporation Reservoir Eluting Stent
AU2010215936B2 (en) 2009-02-21 2015-03-05 Covidien Lp Medical devices having activated surfaces
WO2010095044A2 (en) * 2009-02-21 2010-08-26 Sofradim Production Medical device with degradation-retarding coating
US9139669B2 (en) 2009-03-24 2015-09-22 W. L. Gore & Associates, Inc. Expandable functional TFE copolymer fine powder, the expandable functional products obtained therefrom and reaction of the expanded products
US8658707B2 (en) 2009-03-24 2014-02-25 W. L. Gore & Associates, Inc. Expandable functional TFE copolymer fine powder, the expanded functional products obtained therefrom and reaction of the expanded products
US8591932B2 (en) * 2009-09-17 2013-11-26 W. L. Gore & Associates, Inc. Heparin entities and methods of use
KR101716241B1 (ko) 2009-12-01 2017-03-14 엑스테라 메디컬 코퍼레이션 표면 고정화된 다당류를 이용하여 혈액으로부터 사이토카인을 제거하는 방법
EP2518100B1 (en) 2009-12-24 2015-02-18 Toray Industries, Inc. Hydrophilic polymer compound having anticoagulation effect
GB201004101D0 (en) 2010-03-12 2010-04-28 Carmeda Ab Immobilised biological entities
EP2575681B1 (en) 2010-05-25 2022-06-22 JenaValve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US9839540B2 (en) 2011-01-14 2017-12-12 W. L. Gore & Associates, Inc. Stent
US10166128B2 (en) 2011-01-14 2019-01-01 W. L. Gore & Associates. Inc. Lattice
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
US9415193B2 (en) 2011-03-04 2016-08-16 W. L. Gore & Associates, Inc. Eluting medical devices
US20120310210A1 (en) 2011-03-04 2012-12-06 Campbell Carey V Eluting medical devices
EP3375462B1 (en) 2011-03-11 2023-06-07 W. L. Gore & Associates, Inc. Improvements to immobilised biological entities
TW201311774A (zh) 2011-06-23 2013-03-16 Toray Industries 具有抗血液凝固作用的疏水性高分子化合物
TW201309354A (zh) 2011-06-23 2013-03-01 Toray Industries 醫療材料
US9775933B2 (en) 2012-03-02 2017-10-03 W. L. Gore & Associates, Inc. Biocompatible surfaces and devices incorporating such surfaces
DK2861273T3 (da) 2012-06-13 2017-11-27 Exthera Medical Corp Anvendelse af heparin og kulhydrater til behandling af cancer.
US9283072B2 (en) 2012-07-25 2016-03-15 W. L. Gore & Associates, Inc. Everting transcatheter valve and methods
US9931193B2 (en) 2012-11-13 2018-04-03 W. L. Gore & Associates, Inc. Elastic stent graft
US9144492B2 (en) 2012-12-19 2015-09-29 W. L. Gore & Associates, Inc. Truncated leaflet for prosthetic heart valves, preformed valve
US9968443B2 (en) 2012-12-19 2018-05-15 W. L. Gore & Associates, Inc. Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet
US9101469B2 (en) 2012-12-19 2015-08-11 W. L. Gore & Associates, Inc. Prosthetic heart valve with leaflet shelving
WO2014209782A1 (en) 2013-06-24 2014-12-31 Exthera Medical Corporation Blood filtration system containing mannose coated substrate
EP3038567B1 (en) 2013-08-30 2022-09-07 JenaValve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
CA2928866C (en) 2013-11-08 2021-11-09 Exthera Medical Corporation Methods for diagnosing infectious diseases using adsorption media
CN105744966A (zh) 2013-11-28 2016-07-06 东丽株式会社 抗血栓性材料
EP3078389B1 (en) 2013-11-28 2020-04-01 Toray Industries, Inc. Antithrombotic material
US10842918B2 (en) 2013-12-05 2020-11-24 W.L. Gore & Associates, Inc. Length extensible implantable device and methods for making such devices
US10251742B2 (en) 2014-02-12 2019-04-09 Toray Industries, Inc. Artificial blood vessel
US11839698B2 (en) 2014-03-13 2023-12-12 W. L. Gore & Associates, Inc. Drug composition and coating
JP2017513636A (ja) 2014-04-24 2017-06-01 エクスセラ メディカル コーポレイション 高流量を用いて血液から細菌を除去するための方法
US9827094B2 (en) 2014-09-15 2017-11-28 W. L. Gore & Associates, Inc. Prosthetic heart valve with retention elements
KR20170060062A (ko) 2014-09-22 2017-05-31 엑스테라 메디컬 코퍼레이션 웨어러블 혈액관류 장치
WO2016177562A1 (en) 2015-05-01 2016-11-10 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
EP3095509A1 (en) 2015-05-18 2016-11-23 Defymed Membranes functionalized with heparin for bioartificial organs
US10561766B2 (en) 2015-09-15 2020-02-18 W. L. Gore & Associates, Inc. Drug composition and coating
US10786615B2 (en) 2016-03-02 2020-09-29 Exthera Medical Corporation Method for treating drug intoxication
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
JP7248430B2 (ja) 2016-04-21 2023-03-29 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド 直径を調節可能な内部人工器官ならびに関連したシステムおよび方法
EP4183371A1 (en) 2016-05-13 2023-05-24 JenaValve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
WO2018061916A1 (ja) 2016-09-30 2018-04-05 東レ株式会社 共重合体及びこれを用いた医療材料
JP6863295B2 (ja) 2016-10-07 2021-04-21 東レ株式会社 筒状織物
EP3318294A1 (en) 2016-11-08 2018-05-09 Defymed Kit for in situ delivery of a compound of interest
JP7094965B2 (ja) 2017-01-27 2022-07-04 イエナバルブ テクノロジー インク 心臓弁模倣
EP3603573B1 (en) 2017-03-31 2023-03-22 Toray Industries, Inc. Cylindrical structure
CA3178271A1 (en) 2017-09-27 2019-04-04 W.L. Gore & Associates, Inc. Prosthetic valve with expandable frame and associated systems and methods
CN115024861A (zh) 2017-09-27 2022-09-09 W.L.戈尔及同仁股份有限公司 具有机械联接的瓣叶的假体瓣膜
CA3205219A1 (en) 2017-10-31 2019-05-09 Edwards Lifesciences Corporation Medical valve and leaflet promoting tissue ingrowth
JP6610832B1 (ja) 2018-01-30 2019-11-27 東レ株式会社 平織物、その製造方法およびステントグラフト
US20190275213A1 (en) 2018-03-09 2019-09-12 Carmeda Ab Immobilising biological entities
KR20200129114A (ko) 2018-03-09 2020-11-17 카르메다 아베 생물학적 실체를 고정화하기 위한 방법에 대한 개선
WO2020070258A1 (en) 2018-10-03 2020-04-09 Carmeda Ab Immobilised biological entities
US20200179663A1 (en) 2018-12-11 2020-06-11 W. L. Gore & Associates, Inc. Medical devices for shunts, occluders, fenestrations and related systems and methods
CN113473905A (zh) 2018-12-21 2021-10-01 W.L.戈尔及同仁股份有限公司 具有可调整血流的可植入医疗设备
WO2020158847A1 (ja) 2019-01-30 2020-08-06 東レ株式会社 心血管留置デバイス用の医療基材
US11497601B2 (en) 2019-03-01 2022-11-15 W. L. Gore & Associates, Inc. Telescoping prosthetic valve with retention element
WO2021097412A1 (en) 2019-11-15 2021-05-20 W. L. Gore & Associates, Inc. Left atrial appendage device and methods
CA3168927A1 (en) 2020-02-04 2022-08-11 W. L. Gore & Associates, Inc. Inflow / outflow cannula
EP3892259A1 (en) 2020-04-09 2021-10-13 Defymed Membranes for medical devices
WO2021204935A1 (en) 2020-04-09 2021-10-14 Defymed Membranes for medical devices

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8200751L (sv) * 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
US4600652A (en) 1985-04-01 1986-07-15 Warner-Lambert Company Permanently bonded antithrombogenic polyurethane surface
US5049403A (en) * 1989-10-12 1991-09-17 Horsk Hydro A.S. Process for the preparation of surface modified solid substrates
IT1260136B (it) 1992-04-17 1996-03-28 Alfa Wassermann Spa Glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonicosostituito con radicali nucleofili in posizione 3
US5679659A (en) * 1995-08-22 1997-10-21 Medtronic, Inc. Method for making heparinized biomaterials
US6174326B1 (en) * 1996-09-25 2001-01-16 Terumo Kabushiki Kaisha Radiopaque, antithrombogenic stent and method for its production

Also Published As

Publication number Publication date
DE69909104D1 (de) 2003-07-31
EP1112097B1 (en) 2003-06-25
ATE243538T1 (de) 2003-07-15
NO984143D0 (no) 1998-09-09
PT1112097E (pt) 2003-11-28
JP2003507082A (ja) 2003-02-25
DE69909104T2 (de) 2004-04-08
DK1112097T3 (da) 2003-10-20
BR9913516B1 (pt) 2010-09-21
WO2000013718A1 (en) 2000-03-16
EP1112097A1 (en) 2001-07-04
CA2342991C (en) 2009-01-27
KR100669132B1 (ko) 2007-01-17
US6461665B1 (en) 2002-10-08
JP4152075B2 (ja) 2008-09-17
ES2203177T3 (es) 2004-04-01
CA2342991A1 (en) 2000-03-16
AU757913B2 (en) 2003-03-13
AU5765299A (en) 2000-03-27
KR20010088799A (ko) 2001-09-28
BR9913516A (pt) 2001-06-05

Similar Documents

Publication Publication Date Title
NO984143L (no) Ny prosess for å fremstille overflatemodifiserende stoffer
NO872602L (no) Elektrisk kontaktsett, sŸrlig for bruk under vann.
ES536909A0 (es) Procedimiento para la preparacion de compuestos complejos de piroxicam con ciclodestrinas
DE68902916T2 (de) Herstellung von quecksilberfreiem synthesegas, reduktionsgas oder brenngas.
ES2168006T3 (es) Factor neurotrofico ciliar modificado, metodo de fabricacion y metodos de utilizacion.
EA200000473A1 (ru) Состав модифицированного крахмала для удаления частиц из водных дисперсий
DE69502154T2 (de) Herstellung von cis-1,4-Polybutadien mit verminderter Gelbildung
CA2324887A1 (fr) Composition ophtalmique comprenant un .beta.-bloquant
FI963749A0 (fi) Huokoinen metallikomposiittikappale
ATE237568T1 (de) Neue substanzbibliothek und damit hergestellte supramolekulare komplexe
ES2097103T1 (es) Metodo de producir almidon cationico.
ES2190991T3 (es) Estabilizacion de plaquetas.
NO20012854L (no) Fremgangsmåte for avvanning av organiske v¶sker
ATE357914T1 (de) Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien
ATE246254T1 (de) Verwendung von oxidationsfördernden chemikalien für die oxidation von einem polymer, das die alkoholkonfiguration eines oxidierbaren galaktosetyps enthält.
NO20003151L (no) Kationisk tverrbundet stivelse med stabil og "skreddersydd" viskositet
WO2001042250A3 (en) Process for production of diphenyl-dialkoxysilane, phenylalkyl-dialkoxysilane, octaphenylcyclotetrasiloxane and sym-tetraalkyltetraphenyl-cyclotetrasiloxane
DE69421195D1 (de) Einstufige herstellung von 4,6 dinitroresorcinol aus resorcinol
IT1216721B (it) Procedimento per la produzione di bricchette di combustibile senza fumo trattate.
DE3886225D1 (de) Pyruvat-Oxidase, ihre Herstellung und Verwendung.
KR910008138A (ko) 효소법에 의한 l-세린의 제조법
HUP9900959A2 (hu) Eljárás 3-metoxi-1-propanol előállítására
ATE266670T1 (de) 1,3-diphenylphosphinopropan-liganden und entsprechende übergangsmetallkomplexe, deren herstellung und verwendung
SE9600285D0 (sv) Modification of starch
RU93008855A (ru) Сверло

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application